Wolverine Asset Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Wolverine Asset Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-145,847	Closed	-$1.45M	–	2090
2023 Q1	$1.45M	Buy	145,847 +139,123	+2,069%	+$1.38M	0.02%	596
2022 Q4	$67K	Buy	+6,724	New	+$50.1K	﹤0.01%	1345

Wolverine Asset Management's APEN Position: Q2 2023 in Review

Wolverine Asset Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 145,847 shares — an estimated $1.45M sold.

Wolverine Asset Management first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $1.45M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Wolverine Asset Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Wolverine Asset Management sold 145,847 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $1.45M.
Wolverine Asset Management first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
Wolverine Asset Management's Apollo Endosurgery, Inc. position peaked at $1.45M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.